CDK6 a transcriptional regulator in AML
27 Jun 2018
CDK6 a transcriptional regulator in AML
ASCO 2018 conference round up
First in-human trial of AMV564 for AML
SETBP1 induces transcription of developmental genes
Combination therapy for CLL in the CAPTIVATE trial
Efficacy of novel agents in r/r T pro-lymphocytic leukaemia
Isatuximab in combination to treat relapsed/refractory MM
Specification of haematopoetic stem cell fate via modulation of mitochondrial activity
Onset and treatment of infantile leukaemia
Novel CD22 CAR-T therapy for paediatric leukaemia
A new anti-CD22 CAR T immunotherapy for paediatric leukaemia
Novel ADC for relapsed/refractory lymphoma